The European Patent Office (EPO) has published a preliminary an non-binding
report. The company provides additional information when the company has had
the opportunity to review and assess the report with its patent advisor. 

 As previously announced, EPO has summoned the parties to oral proceedings on
October 15, 2013. 

 For further information please contact:

Christina Thomsen, Investor Relations

Tel. +45 45 29 00 00, mail investor@bioporto.com